Importantly, intratumoral injection of rAd.sT increased CD8+ T lymphocytes and CD4+ T memory cells in the peripheral blood, pointing to a direct anti-tumor immunological effect by suppressing TGF-β signaling. The gene discussed is CD8A; the disease is neoplasm.